Your browser doesn't support javascript.
loading
Eradication Rate by Duration of Third-line Rescue Therapy with Levofloxacin after Helicobacter pylori Treatment Failure in Clinical Practice / 대한소화기학회지
Article em En | WPRIM | ID: wpr-149530
Biblioteca responsável: WPRO
ABSTRACT
BACKGROUND/

AIMS:

This study evaluated the eradication rate of levofloxacin-containing rescue therapy by treatment duration in patients in whom previous first- and second-line treatment failed.

METHODS:

Fifty-five patients with persistent Helicobacter pylori infection after first-line therapy and second-line therapy were studied in a single referral academic center. We compared the eradication rates by the treatment duration of third-line therapy.

RESULTS:

Of 55 patients, 12 (21.8%) received rescue therapy for seven days, 24 (43.6%) received rescue therapy for 10 days, and 19 (34.5%) received rescue therapy for 14 days. The eradication rates of therapy with levofloxacin were 65.5% in the 55 enrolled patients and 73.5% in the 49 patients who underwent follow-up testing. In cases where follow-up testing was performed, the eradication rate of 7-day therapy was 58.3%, of 10-day 68.2%, and of 14-day therapy 93.3%. Eradication rate of 14-day therapy was higher than 7-day (p=0.06) and 10-day (p=0.108), but chance could not be ruled out in the difference among groups.

CONCLUSIONS:

This study showed somewhat increasing of H. pylori eradication rate by extending the duration of levofloxacin-containing rescue therapy to 14 days.
Assuntos
Palavras-chave
Texto completo: 1 Índice: WPRIM Assunto principal: Encaminhamento e Consulta / Seguimentos / Helicobacter pylori / Helicobacter / Falha de Tratamento / Levofloxacino Tipo de estudo: Observational_studies / Prognostic_studies Limite: Humans Idioma: En Revista: The Korean Journal of Gastroenterology Ano de publicação: 2016 Tipo de documento: Article
Texto completo: 1 Índice: WPRIM Assunto principal: Encaminhamento e Consulta / Seguimentos / Helicobacter pylori / Helicobacter / Falha de Tratamento / Levofloxacino Tipo de estudo: Observational_studies / Prognostic_studies Limite: Humans Idioma: En Revista: The Korean Journal of Gastroenterology Ano de publicação: 2016 Tipo de documento: Article